ozone application linked to measurable drop in fibromyalgia impact scores over 12 weeks
Ozone therapy by rectal insufflation significantly decreased FIQ total scores in fibromyalgia patients from a mean of 67.8 at baseline to 57.7 at week 4 (p=0.0002), with improvements sustained through week 12.
What this means for you
Fibromyalgia impact scores reflect how much daily pain, fatigue, and stiffness are getting in the way of normal life. In this finding, those scores dropped meaningfully — and stayed lower for three months. For people managing chronic discomfort, that kind of sustained shift in how the body responds can make a real difference in day-to-day function.
The published research
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.